Absci (ABSI) Cash & Current Investments (2020 - 2026)
Absci's (ABSI) quarterly Cash & Current Investments came in at $125.7 million in Q1 2026, down 6.18% year-on-year from $134.0 million in Q1 2025, and down 12.88% quarter-over-quarter from $144.3 million in Q4 2025.
Absci (ABSI) Cash & Current Investments (2020 - 2026) Analysis & Trends
Absci has disclosed Cash & Current Investments across 7 years of filings, most recently posting $125.7 million for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $125.7 million, down 6.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.7 million (down 6.18% YoY), and the FY2025 annual result was $144.3 million, up 28.35% from the prior year.
- Cash & Current Investments came in at $125.7 million for Q1 2026 at Absci, down from $144.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $226.0 million in Q1 2022 to a low of $97.7 million in Q4 2023.
- The 5-year median for Cash & Current Investments is $134.0 million (2025), against an average of $141.3 million.
- Peak annual rise in Cash & Current Investments reached 107.16% in 2022, while the deepest fall reached 62.28% in 2022.
- Absci's Cash & Current Investments stood at $164.4 million in 2022, then plunged by 40.61% to $97.7 million in 2023, then advanced by 15.12% to $112.4 million in 2024, then rose by 28.35% to $144.3 million in 2025, then decreased by 12.88% to $125.7 million in 2026.
- The last three Cash & Current Investments figures came in at $125.7 million (Q1 2026), $144.3 million (Q4 2025), and $152.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 125.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.71 Mn |
| Dec 31, 2025 | 144.29 Mn |
| Sep 30, 2025 | 152.48 Mn |
| Jun 30, 2025 | 117.46 Mn |
| Mar 31, 2025 | 133.98 Mn |
| Dec 31, 2024 | 112.43 Mn |
| Sep 30, 2024 | 127.07 Mn |
| Jun 30, 2024 | 145.25 Mn |
| Mar 31, 2024 | 161.54 Mn |
| Dec 31, 2023 | 97.66 Mn |
| Sep 30, 2023 | 113.48 Mn |
| Jun 30, 2023 | 124.59 Mn |
| Mar 31, 2023 | 144.26 Mn |
| Dec 31, 2022 | 164.43 Mn |
| Sep 30, 2022 | 105.35 Mn |
| Jun 30, 2022 | 206.02 Mn |
| Mar 31, 2022 | 226.00 Mn |
| Dec 31, 2021 | 252.57 Mn |
| Sep 30, 2021 | 279.26 Mn |
| Jun 30, 2021 | 99.45 Mn |